I-ELCAP
The International Early Lung Cancer Action Program
The International Early Lung Cancer Action Program (I-ELCAP) is an ongoing screening program that began accruing participants in 1994. It initially had two participating institutions, NYU and Cornell and now includes over 80 sites worldwide. The Principal Investigator for this program is Claudia Henschke PhD, MD, who is currently at Mount Sinai, which is the coordinating center for the program. I-ELCAP is the largest multi-center screening program in the world having already accrued over 80,000 participants and new sites continue to enroll. The program strives to be at the forefront of both innovation and clinical care, which has helped to set the standard in screening that has been adopted globally.
IELCART
The Initiative for Early Lung Cancer Research on Treatment
The Initiative for Early Lung Cancer Research on Treatment (IELCART) program launched from the recognition that with an increase in screening-detected Stage I lung cancer diagnoses, there needs to be an emphasis on improving the treatment of these early stage lung cancers. As new sites continue to join this multi-center collaboration, we anticipate accruing at least 1000 cases per year. All sites contribute all of their clinical Stage I lung cancers, including corresponding clinical information and imaging studies. We believe this represents an ideal venue to advance treatment research so that we can continue to improve outcomes for people diagnosed with lung cancer